A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
Kuwanon G protects HT22 cells from advanced glycation end product-induced damage
2021
Experimental and Therapeutic Medicine
The incidence of diabetic encephalopathy is increasing as the population ages. Evidence suggests that formation and accumulation of advanced glycation end products (AGEs) plays a pivotal role in disease progression, but limited research has been carried out in this area. A previous study demonstrated that Kuwanon G (KWG) had significant anti-oxidative stress and anti-inflammatory properties. As AGEs are oxidative products and inflammation is involved in their generation it is hypothesized that
doi:10.3892/etm.2021.9869
pmid:33747164
pmcid:PMC7967837
fatcat:o7rvmmfppvguxk55swbyz7l2bi